134 related articles for article (PubMed ID: 3925118)
1. Effect of liver S9 from 3,4,5,3',4'-pentachlorobiphenyl-pretreated rats on the mutagenic activity of the various carcinogens toward Salmonella typhimurium TA 98.
Ozawa N; Watabe T; Yoshimura H; Koga N; Shudo K
J Pharmacobiodyn; 1985 Mar; 8(3):199-205. PubMed ID: 3925118
[TBL] [Abstract][Full Text] [Related]
2. Effect of cigarette smoke on the mutagenic activation of various carcinogens in hamster.
Mori Y; Iimura K; Furukawa F; Nishikawa A; Takahashi M; Konishi Y
Mutat Res; 1995 Jan; 346(1):1-8. PubMed ID: 7530323
[TBL] [Abstract][Full Text] [Related]
3. Some factors determining the concentration of liver proteins for optimal mutagenicity of chemicals in the Salmonella/microsome assay.
Malaveille C; Kuroki T; Brun G; Hautefeuille A; Camus AM; Bartsch H
Mutat Res; 1979 Dec; 63(2):245-58. PubMed ID: 392308
[TBL] [Abstract][Full Text] [Related]
4. Mutagenic activation of carcinogenic N-nitrosopropylamines by rat liver: evidence for a cytochrome P-450 dependent reaction.
Mori Y; Yamazaki H; Toyoshi K; Makino T; Obara T; Yokose Y; Konishi Y
Carcinogenesis; 1985 Mar; 6(3):415-20. PubMed ID: 3884171
[TBL] [Abstract][Full Text] [Related]
5. Specificity of rat liver cytochrome P-450 isozymes in the mutagenic activation of benzo[a]pyrene, aromatic amines and aflatoxin B1.
Robertson IG; Zeiger E; Goldstein JA
Carcinogenesis; 1983; 4(1):93-6. PubMed ID: 6295661
[TBL] [Abstract][Full Text] [Related]
6. Influence of mouse liver stored vitamin A on the induction of mutations (Ames tests) and SCE of bone marrow cells by aflatoxin B1, benzo(a)pyrene, or cyclophosphamide.
Qin S; Huang CC
Environ Mutagen; 1986; 8(6):839-47. PubMed ID: 3096708
[TBL] [Abstract][Full Text] [Related]
7. Metabolic activation to a mutagen of 3-hydroxy-trans-7,8-dihydroxy-7,8-dihydrobenzo[a]pyrene, a secondary metabolite of benzo[a]pyrene.
Glatt H; Seidel A; Ribeiro O; Kirkby C; Hirom P; Oesch F
Carcinogenesis; 1987 Nov; 8(11):1621-7. PubMed ID: 3311446
[TBL] [Abstract][Full Text] [Related]
8. Salmonella/human S9 mutagenicity test: a collaborative study with 58 compounds.
Hakura A; Shimada H; Nakajima M; Sui H; Kitamoto S; Suzuki S; Satoh T
Mutagenesis; 2005 May; 20(3):217-28. PubMed ID: 15843387
[TBL] [Abstract][Full Text] [Related]
9. Differential mutagenicities of triamino benzenes against Salmonella typhimurium TA98 in the presence of S9 fractions from polychlorinated biphenyls-, phenobarbital- or 3-methylcholanthrene-pretreated rats, hamsters and mice.
Yoshikawa K; Nohmi T; Harada R; Inokawa Y; Ishidate M
J Toxicol Sci; 1979 Nov; 4(4):317-26. PubMed ID: 121315
[TBL] [Abstract][Full Text] [Related]
10. Use of human liver S9 in the Ames test: assay of three procarcinogens using human S9 derived from multiple donors.
Hakura A; Suzuki S; Sawada S; Sugihara T; Hori Y; Uchida K; Kerns WD; Sagami F; Motooka S; Satoh T
Regul Toxicol Pharmacol; 2003 Feb; 37(1):20-7. PubMed ID: 12662906
[TBL] [Abstract][Full Text] [Related]
11. Mutagenic activation of 3-amino-1,4-dimethyl-5H-pyrido(4,3-b)indole(Trp-P-1) and 3-amino-1-methyl-5H-pyrido(4,3-b)indole (Trp-P-2) by primary cultures of adult rat hepatocytes: effect of Aroclor induction in vitro.
Decloître F; Hamon G; Martin M; Thybaud-Lambay V
Mutat Res; 1984; 137(2-3):123-32. PubMed ID: 6433191
[TBL] [Abstract][Full Text] [Related]
12. [Comparative study on the mutagenic activity of rat liver and bladder S9 by fluctuation test].
Hayashi K; Mashizu N; Haga S; Ubukata N; Sakurai M; Shimizu H
Sangyo Igaku; 1988 Sep; 30(5):385-91. PubMed ID: 3060631
[TBL] [Abstract][Full Text] [Related]
13. Mutagenic activation of aflatoxin B1 by several forms of purified cytochrome P-450.
Ishii K; Maeda K; Kamataki T; Kato R
Mutat Res; 1986 Jun; 174(2):85-8. PubMed ID: 3086716
[TBL] [Abstract][Full Text] [Related]
14. The effects of pretreatment with cytochrome P-450 inducers and preincubation with a cytochrome P-450 effector on the mutagenicity of genotoxic carcinogens mediated by hepatic and renal S9 from two species of marine fish.
Guobaitis RJ; Ellingham TJ; Maddock MB
Mutat Res; 1986 Feb; 164(1):59-70. PubMed ID: 3512989
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of the metabolizing capacity of S9 liver preparations from rats and mice using a test with Salmonella typhimurium TA100.
Gajcy H; Pieńkowska K; Koziorowska J; Czarnomska A
Pol J Pharmacol Pharm; 1987; 39(1):27-32. PubMed ID: 3313326
[TBL] [Abstract][Full Text] [Related]
16. Mutagenesis in Salmonella after metabolic activation of carcinogenic azo dyes and their isomers by liver S9 from rats, mice and hamsters.
Mori Y; Niwa T; Toyoshi K; Hirano K; Sugiura M
Mutat Res; 1983 Aug; 121(2):95-102. PubMed ID: 6348534
[TBL] [Abstract][Full Text] [Related]
17. Participation of cytochrome P450 in mutagenic activation of the carcinogen 3'-hydroxymethyl-N,N-dimethyl-4-aminoazobenzene and its N-demethylated compounds by rat liver.
Mori Y; Niwa T; Toyoshi K
Mutat Res; 1983 Oct; 122(1):13-22. PubMed ID: 6413856
[TBL] [Abstract][Full Text] [Related]
18. The reduced mutagenicity of aflatoxin B1 due to hydroxylation: observations on five Salmonella typhimurium tester strains.
Uwaifo AO; Bababunmi EA
Cancer Lett; 1979 Aug; 7(4):221-5. PubMed ID: 389414
[TBL] [Abstract][Full Text] [Related]
19. Genotoxic and mutagenic activation of aflatoxin B1 by constitutive forms of cytochrome P-450 in rat liver microsomes.
Shimada T; Nakamura S; Imaoka S; Funae Y
Toxicol Appl Pharmacol; 1987 Oct; 91(1):13-21. PubMed ID: 3118508
[TBL] [Abstract][Full Text] [Related]
20. Activation and inactivation of a variety of mutagenic compounds by the reconstituted system containing highly purified preparations of cytochrome P-450 from rat liver.
Kawano S; Kamataki T; Maeda K; Kato R; Nakao T; Mizoguchi I
Fundam Appl Toxicol; 1985 Jun; 5(3):487-98. PubMed ID: 3924696
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
